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Abstract
An increasing number of studies suggest inflammation stimulates tumour invasion. In mela-
noma, despite recent advances in targeted therapy and immunomodulatory therapies, this
cancer remains difficult to treat. Our previous studies show melanoma cells interact with
skin cells in their invasion into tissue engineered skin and suggest inflammation stimulates
invasion. The aim of this study was to investigate the use of an anti-inflammatory on mela-
noma invasion. To do this we developed a wounded and inflamed in vitro 3D melanoma
model in which to investigate the use of an anti-inflammatory on melanoma invasion. The
tissue engineered skin model was based on human de-epidermised acellular dermis to
which keratinocytes, fibroblasts and three different melanoma cell lines were added in vari-
ous combinations. A simple incisional wound was made in the model and TNF-α and fibrin
were added to simulate conditions of inflammation. Topical ibuprofen in a hydrogel was
added and the extent of melanoma invasion into the dermis was assessed under the vari-
ous conditions. The results showed that penetration of two of the cell lines (HBL and
A375SM) into the tissue engineered skin was exacerbated by wounding and ibuprofen sig-
nificantly decreased invasion of A375SM cells and slightly reduced invasion of HBL cells. A
third cell line, C8161, was aggressively invasive under all conditions to an extent that was
not influenced by wounding, TNF-α or the addition of ibuprofen. In summary, the results for
one these cell lines (and a trend for a second cell line) support the hypothesis that a wound
environment is conducive to melanoma invasion but the local addition of an anti-inflamma-
tory drug such as ibuprofen may attenuate invasion.
Introduction
Melanoma affects millions of people worldwide [1–4] and its incidence is increasing every
year. While surgical treatment is successful for thin and superficial melanoma which are
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detected at an early stage, for melanoma thicker than 1mm at presentation the prognosis
remains poor due to the aggressive invasion of these transformed melanocytes. The treatments
available are essentially the surgical removal of the primary tumour and melanoma in the
lymph nodes followed by chemotherapy. Historically metastatic melanoma has been one of the
most difficult cancers to treat showing little response to conventional chemotherapy drugs.
However recent years have seen improvements in survival time with drugs targeted to BRAF
and MEK gene mutations in these cancers and with the use of newer immunomodulatory ther-
apies targeted to checkpoint inhibitors.
Thus vemurafenib and trametinib respectively are used to target melanoma cells with BRAF
and MEK gene mutations [5]. Post lymph-node dissection and therapy with BRAF and MEK
inhibitors increased survival is reported. For example, vemurafenib has been found to be safe
in patients with BRAF (V600) mutated metastatic melanoma [6], and combined therapy of
drabrafenib and trametinib significantly improved overall survival in comparison to vemurafe-
nib monotherapy alone [7]. Another combined therapy of vemurafenib and cobimetinib in
patients with advanced BRAF (V600)-mutant melanomas has also been reported to be promis-
ing [8]. While immunotherapeutic drugs such as interferon and anti-CTLA4 antibodies remain
under clinical investigation [9], the newer immunotherapies ipilimumab given with MAPK-
targeted vemurafenib, dabrafenib and trametinib have demonstrated long term improvement
in patient outcome, a benefit not afforded by traditional therapeutics [10].
Despite this, melanoma remains very challenging to treat and more knowledge on the meta-
static process used by these tumours is needed. The metastasis of this aggressive tumour has
been studied extensively and there is a growing literature suggesting that inflammation plays a
role in many cancers [11, 12]. This study follows on from our earlier work suggesting a stimula-
tory effect of inflammation in melanoma [13] and is based on the clinical phenomenon of
“local recurrence” of melanoma after surgical excision of the primary melanoma tumour. For
some patients melanomas can re-occur in the excised wound bed some months after excision
of the primary tumour sites. One theory which has been investigated to a slight extent is that
the act of primary melanoma excision creates a wound bed environment with upregulation of
degradative enzymes and pro-inflammatory cytokines which is conducive to the subsequent
attachment and migration of circulating melanoma cells. This has been tested in an animal
study [14] where a wound bed was created anatomically distant to the site of primary mela-
noma. Post-excision of the primary melanoma “local recurrence” occurred at this wound bed
site. This argues strongly in support of the hypothesis that the factors which are part of the
physiological response to wounding are also unfortunately conducive to melanoma attach-
ment, migration and invasion.
In normal wound healing the sequence of events which occurs is complex and it is very diffi-
cult to study the effects of mechanical trauma separately to the effects of pro-inflammatory
cytokines. Also it is not possible to ask questions of whether the stromal cells on their own
stimulate or inhibit melanoma invasion or whether it is a combination of the keratinocytes and
the fibroblasts which influence tumour progression. Tissue engineered models of skin offer
opportunities to look at some of these factors in isolation and our experiences to date have
yielded some interesting findings which could not readily have been detected from conven-
tional 2D cell culture experiments or indeed from animal models. Essentially, our in vitro
results show melanoma cell invasion influences and is influenced by adjacent skin cells [15, 16]
and our evidence based on both 2D and 3D models suggests that inflammation can exacerbate
melanoma invasion [15, 16] and anti-inflammatories can reduce invasion [16–19].
The aim of this study therefore was to develop in vitro models of wounded and inflamed
skin to learn more about the factors that may influence melanoma invasion and hence develop
new approaches to reducing this. We developed an incisional human skin wound model and
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looked at the ability of three different melanoma cells varying in their metastatic potential to
invade in this model under non-wounded and wounded conditions and we looked at the
impact of adding a major pro-inflammatory cytokine TNF-α (Tumour Necrosis Factor-alpha),
and fibrin (which would normally be found in a wound healing response) to these wounds.
Finally, we looked at the effect of adding a non-steroidal anti-inflammatory, ibuprofen, to mel-
anoma cells invading in this model.
These results provide further evidence for a wound healing environment being conducive to
melanoma invasion but encouragingly provide evidence that the local addition of a clinically
acceptable anti-inflammatory such as ibuprofen can attenuate this invasion.
Materials and Methods
Materials
Cell culture media, antibiotics and additives were purchased from Gibco BRL (Life Technolo-
gies, Paisley, UK). Foetal calf serum (FCS), Pluronic F-127 polymer. Fibrinogen, thrombin
(from bovine plasma) and sodium hydrogen carbonate were all purchased from Sigma-Aldrich
(Poole, Dorset, UK). TNF-α was purchased from GlobePharm Limited (Esher, UK); Trypsin/
ethylenediamine-tetraacetic acid (EDTA) and phosphate-buffered saline (PBS) tablets were
purchased from Oxoid Ltd. (Basingstoke, UK). Paraformaldehyde was purchased from BDH/
Merck, Poole, Dorset, UK. Rabbit-derived S-100 antibody; mouse-derived HMB45 antibody;
and, mouse anti-cytokeratin AE1AE3 antibody were purchased from Dako (Carpintera, CA,
USA).
Culture of Melanoma Cells
The HBL cell line was derived from a lymph node metastasis of a nodular melanoma estab-
lished in one of our laboratories [20]. The A375-SM cell line was a generous gift from Professor
IJ Fidler (USA) via Professor MJ Humphries (University of Manchester, UK). A375 was estab-
lished in culture from a lymph node metastasis of a 54-year-old female [21]. These cells are het-
erogeneous in nature and a highly metastatic variant (A375-SM) was established in culture
from lung metastases produced by parental A375 cells growing subcutaneously in nude mice
[22]. The C8161 melanoma line was kindly donated by Professor F Meyskens (University of
California, Irvine, USA) via Professor M Edwards (University of Glasgow, UK). C8161 was
established from an abdominal wall metastasis [23].
C8161 and A375SM melanoma cells were cultured in Eagle`s modified essential medium
(EMEM) supplemented with 10% FCS, 2mM L-Glutamine, 100 units/ml penicillin, and 100μg/
ml streptomycin sulphate, 1.2 mg/ml amphotericin B, 1.5% (of 100x stock solution) vitamin
concentrate, 1mM sodium pyruvate, 1% non-essential amino acids (NEA) and 0.187% sodium
hydrogen carbonate. Cells were incubated at 37°C in a humidified 5% carbon dioxide/95% air
environment under standard conditions and passaged prior to confluence using 0.002% ethyle-
nediamine tetraacetic acid (EDTA). Cells were used between passages 30–60 for
experimentation.
HBL cells were maintained in melanoma culture medium, which consists of Ham’s F10
medium supplemented with 5% FCS; 5% NBCS; 2 x 10−3 mol/L glutamine; 100 IU/mL penicil-
lin and 100 μg/mL streptomycin. Cells were passaged when 80–90% confluent.
Production of de-epidermised acellular dermis (DED)
Skin was obtained from split-thickness skin grafts (STSGs) from patients undergoing routine
plastic surgery for breast reduction and abdominoplasties. Patients gave written informed
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consent for tissue not required for their treatment to be used for research purposes. All tissue
was banked on an anonymous basis under a Human Tissue Authority Research Tissue Bank
Licence, Number 12179. Ethical approval for this Research Tissue Bank was obtained from the
National Research Ethics Service (NRES) Committee Yorkshire & The Humber–Sheffield
(REC ref: 15/YH/0177).
STSGs were stored in PBS for a minimum of 48 h and then immersed in sterile 1 mol/L
sodium chloride for 18h, resulting in an acellular de-epidermised human dermis (DED). The
epidermis was separated from the underlying dermis using forceps and the remaining DED
samples were washed several times in PBS, then stored in DMEM supplemented with 5% FCS,
2 x 10−3 mol/L glutamine, 100 IU/mL penicillin, 100 μg/mL streptomycin and 0.625 μg/mL
amphotericin B. This medium is referred as to fibroblast culture medium (FCM).
Culture of Keratinocytes
STSGs were obtained as previously described. Samples of this skin were cut into 0.5 cm2 pieces
using a scalpel blade and were incubated overnight (12–24 h) at 4°C in 0.1% w/v trypsin. FCS
was added to neutralize the trypsin and the epidermal and dermal layers were carefully sepa-
rated using a pair of forceps with fine points. A scalpel blade was used to gently scrape basal
keratinocytes from the under surface of the epidermis and the papillary surface of the dermis.
The cells were collected into a mixture of FCS and PBS in sterile 25 ml universal containers.
The cell suspension was then centrifuged at 300g for 5 min and the cells were resuspended in a
known volume of keratinocyte culture medium (KCM). This medium consists of DMEM and
Ham’s F12 medium in a 3:1 ratio supplemented with 10% FCS, 10 ng/mL EGF; 0.4 μg/mL
hydrocortisone; 1.8 x 10−4 mol/L adenine; 5 μg/mL insulin; 5 μg/mL transferrin; 2 x 10−3 mol/L
glutamine; 2 x 10−7 mol/L tri-iodo thyronine; 0.625 μg/mL amphotericin B; 100 IU/mL penicil-
lin and 100 μg/mL streptomycin. A cell count was carried out using a haemocytometer, and
trypan blue exclusion was used to assess cell viability. Keratinocytes were not used above pas-
sage 3.
Culture of Fibroblasts
STSGs were trypsinized as described previously for the isolation of keratinocytes. The epider-
mal and dermal layers were separated and the dermal pieces were washed several times in ster-
ile PBS and then finely minced with a scalpel blade. The dermal mince was incubated at 37°C
overnight in 10 ml of a 0.5% collagenese A solution. The following day, the collagenase digest
was spun down in a centrifuge at 300 g for 10 min, the supernatant was discarded and the pellet
of cells was resuspended in FCM. Cells were passaged when fibroblasts reached 80–90% conflu-
ence using 2 ml of a 1:1 mixture of 0.1% w/v trypsin and 0.02 5 w/v EDTA per flask. Fibroblasts
were used between passages 4 and 8.
Tissue Engineered (TE) Human Skin and Melanoma Models
De-cellularised human skin was prepared as described above which resulted in a DED, with
retained basement membrane antigens. Dermal fibroblasts were seeded onto the reticular sur-
face of DED at a concentration of 1 x 105 cells/construct ring. After 48 h, melanoma cells (5 x
104 cells/construct ring) and epidermal keratinocytes (1 x 106 cells/construct ring) were added
to the papillary DED surface. After 48 h, the tissue engineered skin constructs were raised to an
air-liquid interface. Non-wounded constructs were cultured for 15 days and the culture
medium was changed every 2–3 days. Paraffin-fixed histology sections (4 μm) were made for
H&E (Haematoxylin and Eosin) staining. For a full characterisation of these models see [15].
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After 2–3 days at an air-liquid interface, the skin constructs were ready for wounding. The
wounds were made using a scalpel blade, making a simple cut in a cell seeded area through the
epidermal layer into the dermis. In some experiments 30–50μl fibrin clot solution plus 300U/
ml TNF-α were also added to the wounds.
Once the TE skin models had been exposed to an air-liquid interface for 10 days, they were
wounded and cultured for another 9 days–so total elapsed time was 19 days. They were fixed in
10% phosphate buffered formaldehyde for at least 24h before routine histological staining for
H&E. All samples were assessed for overall morphology, examining the presence and organisa-
tion of keratinocytes and fibroblasts in the skin and assessing melanoma cell invasion into the
reconstructed human skin. In some experiments immunohistochemistry was undertaken to
identify keratinocytes (using AE1AE3 antibody), HBL cells (using S100) and A375SM (using
HMB45 antibody). (Unfortunately C8161 cannot be identified with either S100 or HMB45—
please see [15] for a full description).
To quantify melanoma cell invasion into the constructs, an invasion score was used as previ-
ously established by [15]. The score was based on the number of cells invaded into the dermis
counted in each 3D skin model slide. A score of 0 indicates no cells detected in the dermis, a
score of 1 represents 6–15 cells in the dermis, a score of 2 represents 21–30 cells in the dermis
and finally, a score 3 or above was taken as evidence of clear invasion of cells (greater than 30
cells per section).
Statistical Analysis
To analyse the differences between melanoma cell invasion in 3D tissue engineered skin mod-
els, a Kruskal-Wallis 1-way ANOVA test appropriate for multiple comparisons was used to
compare all pairs. This analysis was undertaken using IBM SPSS (Statistical Package for the
Social Sciences) Version 22.
Results
Invasion of melanoma cells into tissue engineered skin
This TE skin model normally has a well defined epidermal layer securely attached to the under-
lying dermis with a reasonable degree of epithelial organisation in the epidermis ranging from
basal cells with large nuclei to superficial layers lacking nuclei. The dermis contains a relatively
low density of cells—identified as dermal fibroblasts. This is shown in Fig 1A at x4 magnifica-
tion where the organisation of the epidermis and dermis is similar to that of normal human
skin. We have deliberately worked with 3 melanoma cell lines selected to be very different in
their invasive behaviour, HBL cells which are not normally very invasive and can be identified
by staining with HMB45, A375SM cells–more aggressively invasive and these can be stained
with S100 and a third cell line, C8161, which is highly invasive. These cells cannot be stained
with either HMB45 or S100. Accordingly we stained the keratinocytes present in these TE con-
structs with an antibody to AE1AE3.
Fig 1B shows HBL cells did not disturb the epithelial layer to a great degree. Fig 1C shows
that A375SM cells were present in the deeper layers of the epidermis. Also in these models ker-
atinocytes are shown to invade the papillary layer of the dermis in the presence of A375SM
cells. (This is aberrant behaviour for these cells as can be seen from quantitative analysis in Fig
2). In Fig 1D the behaviour of C8161 cells is shown. These cells invaded into the papillary and
reticular layers of the dermis. Some keratinocytes were also present in the dermal layer in these
skin models identified by staining with AE1AE3.
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Table 1 compares the invasion scores for the 3 cell lines which shows that the difference in
invasion between the HBL and A375SM cells was not significant in this model, whereas the
invasion of C8161 cells was statistically greater than either of the other two cell types.
Influence of skin cells on melanoma invasion
In these experiments (Fig 2) TE constructs were prepared so that they contained fibroblasts
and keratinocytes (as in normal human skin), melanoma cells alone, melanoma cells and fibro-
blasts or melanoma cells and fibroblasts and keratinocytes. The extent of cellular invasion into
the dermis was then quantified. As can be seen in the standard TE constructs there was no evi-
dence of epidermal cell invasion into the dermis in 22 out of 22 constructs. This result was
expected as in these TE models there were no melanoma cells present and hence, no influence
of melanoma cells on normal skin cell organisation in these 3D skin models. For HBL cells,
these were moderately invasive into the dermis on their own but the presence of fibroblasts
Fig 1. Invasion of melanoma cells into tissue engineered skin. (A) Control TE skin constructs to which fibroblasts and keratinocytes were added
to the DED (4x magnification); (B) Skin cells (fibroblasts and keratinocytes) and HBLmelanoma cells in DED stained with HM45 antibody staining
(40x magnification); (C) Skin cells (fibroblasts and keratinocytes) and A375SM cells stained with S100 antibody staining for A375SM cells (40x
magnification); (D) Skin cells (fibroblasts and keratinocytes) and C8161 cells in DED, AE1AE3 antibody staining for keratinocytes only (40x
magnification). (DED = De-Epidermised acellular Dermis; F = Fibroblasts; K = Keratinocytes).
doi:10.1371/journal.pone.0156931.g001
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completely blocked their invasion (p = 0.001) while the presence of keratinocytes and fibro-
blasts slightly reduced their invasion (p = 0.036). On further examination HBL cells in con-
structs containing fibroblasts and keratinocytes were slightly (not significantly) more invasive
compared to HBL in skin constructs containing only fibroblasts. A375SM cells were not very
invasive on their own in the dermis (invasion score of 0.5 out of 3.0) but there was no invasion
of these cells at all in the presence of fibroblasts. A375SM cells in constructs containing fibro-
blasts and keratinocytes were significantly more invasive than A375SM cells in the presence of
fibroblasts (p = 0.011). Comparing the melanoma invasion seen in the presence of both kerati-
nocytes and fibroblasts to that seen in the presence of fibroblasts alone it is clear that fibroblasts
on their own reduced HBL and A375SM invasion whereas keratinocytes tended to exacerbate
it.
In contrast, C8161 cells were extremely invasive (achieving a near maximal score of 3.0 out
of 3.0 for 12 out of the 13 TE constructs examined). The addition of fibroblasts had no
Fig 2. Quantitation of melanoma cell invasion into the 3D skin models. The composition of cells in these models is given followed by the number of
skin constructs. The maximum invasion score is indicated in brackets. The histograms show the mean +1SEM of all scores. * indicates p<0.05; **
indicates <0.01. (F = fibroblasts, K = keratinocytes).
doi:10.1371/journal.pone.0156931.g002
Table 1. Comparisons of invasion scores in TEmodels containing different melanoma cell lines.
Skin Constructs Invasion Score p-value
[F+K+HBL] vs [F+K+A375SM] 0.3 vs 1.21 0.172
[F+K+HBL] vs [F+K+C8161] 0.3 vs 2.67 0.000***
[F+K+A375SM] vs [F+K+C8161] 1.21 vs 2.67 0.001**
F = Fibroblasts; K = Keratinocytes
**p<0.01
***p<0.001.
doi:10.1371/journal.pone.0156931.t001
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significant effect on this, nor did the addition of fibroblasts and keratinocytes. This melanoma
cell line remained aggressively invasive in all experiments and was always more invasive than
A375SM and HBL cells under the same conditions.
Development of wounded TE skin model with inflammation
Fig 3 shows the development of the wounded skin model. A simple incisional wound was made
in the acellular DED, as shown in Fig 3A. This cannot heal as it lacks cells. Fig 3B shows acellu-
lar DED to which fibrin has been added following wounding. The presence of fibrin physically
reconnected both sides of wound. Fig 3C shows DED plus fibroblasts plus wounding. This
wound completely healed by 14 days due to the presence of the fibroblasts. Fig 3D shows a
wounded DED to which was added fibroblasts and a fibrin clot and this took longer to achieve
to complete healing. Fig 3E shows TE skin constructs containing keratinocytes, fibroblasts and
one of the melanoma cell lines, A375SM, post-wounding (at 4x magnification). This shows a
wide injury that actually increased in size over 14 days. A higher magnification can be seen in
Fig 3F and 3G. This open wound in a TE skin containing A375SM cells may indicate a possible
delay in healing caused by the presence of melanoma cells. Both Fig 3H and 3I show TE skin
containing keratinocytes and fibroblasts post-wounding and the addition of fibrin and TNF-α.
In Fig 3H there is damage to the dermis but the wound has largely healed and there is a contin-
uous epidermis. In Fig 3I the epidermal layer is continuous but the underlying dermal wound
is still evident. Comparing these two skin constructs, the results suggest that epidermal healing
may be independent of dermal healing in this model.
Table 2 summarises the various conditions that were evaluated in the development of a
wounded skin model containing the pro-inflammatory cytokine TNF-α. From this, it appears
that a wounded skin model containing fibroblasts or fibroblasts plus fibrin has a good chance
of healing. A wounded skin model containing keratinocytes and fibroblasts (as shown in the
examples of Fig 3H and 3I) may show partial healing, particularly of the epidermal layer.
Effect of sodium ibuprofen on melanoma invasion
Fig 4 shows examples of melanoma cells invading into deliberately wounded skin and the
impact of adding ibuprofen. Fig 4A and 4B shows that HBL cells appear to be in the dermis fol-
lowing wounding. Fig 4C and 4D indicate that following the addition of sodium ibuprofen
there may be less invasion.
With respect to A375SM cells these were moderately invasive and more invasive following
wounding (see almost healed wound) (Fig 4E). Fig 4F shows that following the addition of
sodium ibuprofen gel there was reasonable healing and less invasion.
With respect to C8161 cells their invasion post wounding is shown in Fig 4G. The most
striking finding was that the dermis appeared to be very compact and intact in the presence of
these cells even following wounding. Detailed examination showed extensive invasion of these
C8161 cells throughout the dermis despite the compact integrity of the dermis. These cells
were identified as melanoma on the basis of their large nuclei and the fact that they did not
stain for keratinocytes and were far too plentiful for fibroblasts (which also had smaller nuclei).
This invasion was not affected by the addition of ibuprofen as shown in Fig 4H where dermal
integrity remained very good but C8161 penetration was extensive throughout the dermis.
Examples of the impact of sodium ibuprofen on melanoma invasion are shown in Fig 5
which shows results from four such experiments where it was noticeable that in these models,
which were all deliberately wounded and then a fibrin clot and 300U/ml TNF-α added, the
integrity of the resulting dermis was very poor and the wound repair was variable in the
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absence of ibuprofen (see Fig 5A, 5C, 5E and 5G). In contrast, the wound repair and the quality
of the dermis were much better where ibuprofen was present (see Fig 5B, 5D, 5F and 5H).
The effect of the presence of melanoma cells on dermal integrity was then analysed asking
to what extent did melanoma cells damage or improve the dermal integrity.
Using a simple description of dermal integrity as either good or poor quality this analysis
was as follows. In standard TE skin constructs 20 out of 22 (91%) of experiments were judged
to have good quality dermis (as seen in Fig 1A). In Fig 4 experiments containing HBL cells, 4
had good quality dermis (66%) and 2 poor quality dermis. In 19 experiments containing
A375SM cells, 15 (79%) showed a good dermal quality while 4 (21%) had a poor dermal qual-
ity. Interestingly all 15 skin constructs containing C8161 cells showed good dermal quality
(100%). Thus there is some suggestion that HBL and A375SM cells reduced dermal quality but
clearly C8161 did not.
Quantitation of the effects of wounding and inflammation on melanoma
cell invasion in TE skin
Fig 6 shows the summarised results for a large number of experiments looking at the impact of
wounding and the pro-inflammatory cytokine TNF-α and the anti-inflammatory ibuprofen on
melanoma invasion into TE skin. This data is also summarised in Table 3 which indicates the
number of experiments undertaken and the individual experimental results. In Fig 6A, HBL
cells are weakly invasive but there is a significant increase in invasion in the dermis following
mechanical wounding (p˂0.01). Addition of TNF-α in media or fibrin clots and TNF-α or
sodium ibuprofen did not reduce invasion of HBL cells (p>0.05). Invasion of HBL in wounded
skin constructs, however, was reduced by the addition of TNF-α (p=0.036) or fibrin plus TNF-
α (p=0.008). The addition of ibuprofen on its own did not significantly reduce the invasion of
these cells.
Fig 3. Effect of mechanical wounding and addition of fibrin and TNF-α on wound healing in TE skin. (A) DED+Wound (4x
magnification); (B) DED+Wound+Fibrin (4x magnification); (C) DED+Fibroblasts+Wound (10x magnification); (D) DED+Fibroblasts+Wound
+Fibrin (10x magnification); Wounded standard skin constructs (E, F and G) (4x, 10x and 10x magnifications respectively). Wounded
standard skin constructs with the addition of fibrin and TNF-α (H and I) (10x magnification). The site of the wound is indicated by an arrow.
DED = De-Epidermised acellular Dermis, F = Fibroblasts, W =Wound.
doi:10.1371/journal.pone.0156931.g003
Table 2. Effect of fibrin clot, TNF-α and skin cells on wound healing.
Fibroblasts Wound Fibrin TNF-α Keratinocytes Result
- - - - - Normal DED
- - + - - Normal DED
- + - - - Open wide wound (Fig 3A)
- + + - - Narrowed wound (Fig 3B)
+ - - - - Normal Dermis + F
+ - + - - Normal Dermis + F
+ + - - - Healed (Fig 3C)
+ + + - - Narrowed wound (Fig 3D)
+ + - - + Open wide wound (Fig 3E, 3F and 3G)
+ + + + + Epidermis healed, healed wound (Fig 3H)
+ + + + + Epidermis healed, narrowed wound (Fig 3I)
Fibrin = Fibrin Clots, TNF = 300U/ml TNF-α, F = Fibroblasts.
doi:10.1371/journal.pone.0156931.t002
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In Fig 6B results with A375SM cells are seen. These are moderately invasive cells. Invasion
was slightly increased following wounding (although not significantly so, p = 0.166). The addi-
tion of fibrin reduced invasion but not to a significant level (p = 0.071). The addition of TNF-α
did not affect invasion (p = 0.833). The addition of a control hydrogel did not reduce invasion
(p = 0.114) but when this hydrogel contained ibuprofen cell invasion was decreased although
not to a significant level (p = 0.08). Compared to wounded A375SM TE models, invasion was
significantly reduced by the addition of fibrin (p = 0.018) and by Ibuprofen hydrogel
(p = 0.022). A significant reduction was observed in A375SM TE models treated with sodium
ibuprofen hydrogel compared to the ones treated with a control hydrogel (p = 0.014).
In Fig 6C C8161 cells showed extensive invasion pre-wounding and post-wounding and
this was not changed by the subsequent addition of fibrin plus TNF-α or by the addition of ibu-
profen (p = 0.064). Essentially, these cells remained aggressively invasive under all conditions.
In summary, the three melanoma cell lines showed similar invasion scores in wounded skin
constructs. Ibuprofen hydrogel reduced melanoma cell invasion in two of the least invasive cell
lines. A summary of these results can be seen in Table 4.
Effects of Melanoma Cells on Wound Healing
Finally, the impact of the melanoma cells on wound healing over 15 days was examined. Heal-
ing was assessed as no healing, intermediate healing or good healing. This was a subjective and
observational method considering an open wound, a partially open wound (or partially healed
wound) and a wound completely closed from the epidermis to the dermis as summarised in
Table 5. HBL containing TE skin constructs proved to be the most difficult to heal as 10 out of
14 (71.4%) did not heal. A few of these skin constructs (3 out of 14, or 21.4%) showed some
intermediate healing and only 1 out of 14 (10%) showed good healing. A375SM cells were
slightly better at healing as 6 out of 14 (43.8%) healed, with an intermediate healing in 5 out of
14 (35.7%) whilst only 3 out of 14 (21.4%) did not heal. For C8161 cells 7 out of 7 wounded TE
constructs healed completely (100%).
This is an unexpected result as one might expect wound healing to relate simply to the exent
of melanoma invasion into the dermis. Thus one would expect that the least invasive mela-
noma cells (HBL) would not affect wound healing whilst the most invasive melanoma cells
(C8161) would cause more tissue destruction with delayed wound healing. The only results
which were as expected were shown by A375SM cells which were moderately invasive and led
to TE constructs with moderate wound healing characteristics.
Discussion
The aim of this study was to design physiologically relevant 3D models in which to investigate
aspects of wound healing, inflammation and the use of a common anti-inflammatory on mela-
noma invasion.
The TE constructs were prepared so that they contained all combinations of cells—a great
advantage of using these 3D models as clearly one cannot do such experiments in vivo. Each of
the melanoma cells we investigated behaved very differently (as expected from our selection of
Fig 4. Examples of the effect of sodium ibuprofen onmelanoma invasion. Wounded skin constructs. (A and B) DED+F+K+HBL cells (10x and
40x magnifications respectively); (C and D) F+K+HBL cells+100μMNaIbu in media (10x and 40x magnifications respectively); (E) constructs
containing DED+F+K+A375SM that have been wounded and a fibrin clot placed in the wound and which have also received TNF- α (300U/ml) (10x
magnification); (F) A375SMMelanoma skin construct to which were added fibrin clots plus TNF-α (300U/ml) and a further treatment with 100μMNaIbu
hydrogel (30μl volume), (10x magnification); (G) Effects of NaIbu hydrogel on wound healing of wounded melanoma skin constructs, DED+F+K
+C8161; (H) F+K+C8161+NaIbu hydrogel 131μM (10x magnification). The site of the wound is indicated by an arrow. (DED = De-Epidermised
acellular Dermis, F = Fibroblasts, K = Keratinocytes, W =Wound).
doi:10.1371/journal.pone.0156931.g004
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Fig 5. Effects of Ibuprofen on woundedmelanoma skin construct model. All constructs contained fibroblasts, keratinocytes and A375SM
cells and fibrin clots plus 300 U/ml TNF-α (as in A and C). To (E) and (G) was added unloaded gel. To (B), (D), (F) and (H) were added 100μM
NaIbu hydrogel. (B), (C), (D), (E), (G) and (H) = 4x magnification; (A) and (F) = 10x magnification. The site of the wound is indicated by an arrow.
DED=De-Epidermised acellular Dermis, F=Fibroblasts, K=Keratinocytes, W=Wound.
doi:10.1371/journal.pone.0156931.g005
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Fig 6. Quantitation of the effects of wounding and Ibuprofen onmelanoma cell invasion in TE skin
constructs. (A) with HBL cells, (B) with A375SM cells and (C) with C8161 cells. To the constructs were added
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melanoma cell lines of varying metastatic potential). Indeed each melanoma cell had a distinc-
tive invasive behaviour. The least invasive, HBL cells, are based on melanoma cells derived
from a lymph node tumour. A375SM showed an intermediate invasion and these cells were
obtained from a lymph node metastasis from parental A375 cells which were established in cul-
ture from lung metastasis grown subcutaneously in nude mice. The highest invasive potential
was shown by C8161 cells which are derived from an abdominal wall metastasis. These results
clearly showed three invasive behaviours of these melanoma cells in TE skin as previously
reported from our laboratory by Eves et al. [15].
The addition of HBL cells slightly affected the normally well organised epithelium of this TE
skin model [24] but there was very little disruption to the dermal layer. Addition of A375SM
cells showed melanoma cells (identified by antibody staining for S100 cell marker) mainly
within the epidermal layer which became poorly organised. There were also cells within the
dermis which were identified as keratinocytes (by staining for AE1AE3 cell marker). These are
not normally present in the dermis in the absence of melanoma cells. In contrast, the addition
of C8161 cells led to an extensive florid invasion of these cells into the dermis. Very few of
these cells were identified as keratinocytes by specific staining for the latter cells in the dermis.
W=Wound, Fn=Fibrin clots, TNF=300U/ml TNF-α, NaIbu=Ibuprofen sodium salt as shown. Values (bars) are
expressed as Mean+SEM of invasion score. * indicates p<0.05; ** indicates p<0.01.
doi:10.1371/journal.pone.0156931.g006
Table 3. Effects of NSAID onmelanoma invasion in wounded skin constructs.
Invasion Score
Skin Constructs Total Number of Experiments 0 0.5 1 1.5 2 2.5 3 Mean Invasion Score
F+K 22 22 0
F+K+W 1 1 0
F+K+W+Fn+TNF-α # 3 2 1 0.83
F+K+HBL 6 4 2 0.3
F+K+HBL+W 6 2 1 1 2 2.25 **
F+K+HBL+W+TNF-α (in media) 2 1 1 0.5
F+K+HBL+W+Fn+TNF-α 6 3 3 0.5
F+K+HBL+W+ NaIbu 100μM 2 1 1 0.75
F+K+A375SM 19 7 2 1 2 2 2 3 1.21
F+K+A375SM+W 2 1 1 2.5
F+K+A375SM+W+Fn 3 3 0
F+K+A375SM+W+Fn+TNF-α 7 3 3 1 0.86
F+K+A375SM+W+Fn+TNF-α+Unloaded hydrogel 2 1 1 2.75
F+K+A375SM+W+Fn+TNF-α+NaIbu 100μM hydrogel 5 4 1 0.2
F+K+C8161 15 2 1 12 2.67
F+K+C8161+W 1 1 3
F+K+C8161+W+Fn+TNF-α 4 1 2 1 1.88
F+K+C8161+W+Unloaded hydrogel 2 2 3
F+K+C8161+W+NaIbu 131μM hydrogel 2 2 3
# = Invasion of Keratinocytes
F = Fibroblasts, K = Keratinocytes, W = Wound, Fn = Fibrin clots, TNF = 300U/ml TNF-α, Unloaded Gel = Hydrogel without Sodium Ibuprofen.
NaIbu100μM Gel = Sodium Ibuprofen hydrogel 100μM.
** p˂0.01.
doi:10.1371/journal.pone.0156931.t003
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The residual epidermis was poorly organised while paradoxically the dermis itself remained
compact.
HBL cells were slightly invasive into the dermis on their own but the presence of fibroblasts
completely blocked their invasion. The presence of keratinocytes and fibroblasts only slightly
reduced their invasion. A375SM cells were not very invasive on their own in the dermis and as
for HBL cells, invasion was completely blocked by the addition of fibroblasts. However, these
cells were most invasive in the presence of both keratinocytes and fibroblasts. For these two cell
lines it is clear that fibroblasts alone reduced the invasion of both HBL and A375SM cells
whereas keratinocytes tended to assist their invasion. In contrast, C8161 cells were extremely
invasive in all experiments and unaffected by the presence of fibroblasts or keratinocytes.
Table 4. Comparisons of invasion scores in woundedmelanoma TEmodels.
Skin Constructs Invasion
Score
p-value
[F+K+HBL] vs [F+K+HBL+W] 0.3 vs 2.25 0.001**
[F+K+HBL] vs [F+K+HBL+W+TNF-α (media)] 0.3 vs 0.5 0.788
[F+K+HBL] vs [F+K+HBL+W+Fn+TNF-α] 0.3 vs 0.5 0.734
[F+K+HBL] vs [F+K+HBL+W+NaIbu100μM] 0.3 vs 0.75 0.485
[F+K+HBL+W] vs [F+K+HBL+W+TNF-α (media)] 2.25 vs 0.5 0.036*
[F+K+HBL+W] vs [F+K+HBL+W+Fn+TNF-α] 2.25 vs 0.5 0.008**
[F+K+HBL+W] vs [F+K+HBL+W+NaIbu100μM Gel] 2.25 vs 0.75 0.096
[F+K+A375SM] vs [F+K+A375SM+W] 1.21 vs 2.5 0.116
[F+K+A375SM] vs [F+K+A375SM+W+Fn] 1.21 vs 0 0.071
[F+K+A375SM] vs [F+K+A375SM+W+Fn+TNF-α] 1.21 vs 0.86 0.833
[F+K+A375SM] vs [F+K+A375SM+W+Fn+TNF-α+Unloaded Gel] 1.21 vs 2.75 0.114
[F+K+A375SM] vs [F+K+A375SM+W+Fn+TNF-α+ NaIbu100μM Gel] 1.21 vs 0.2 0.08
[F+K+A375SM+W] vs [F+K+A375SM+W+Fn] 2.5 vs 0 0.018*
[F+K+A375SM+W] vs [F+K+A375SM+W+Fn+TNF-α] 2.5 vs 0.86 0.167
[F+K+A375SM+W] vs [F+K+A375SM+W+Fn+TNF-α+Unloaded Gel] 2.5 vs 2.75 0.885
[F+K+A375SM+W] vs [F+K+A375SM+W+Fn+TNF-α+ NaIbu100μM Gel] 2.5 vs 0.2 0.022*
[F+K+A375SM+W+Fn+TNF-α+Unloaded Gel] vs [F+K+A375SM+W+Fn+TNF-α
+ NaIbu100μM Gel]
2.75 vs 0.2 0.014*
[F+K+HBL+W] vs [F+K+A375SM+W] 2.25 vs 2.5 0.557
[F+K+HBL+W] vs [F+K+C8161+W] 2.25 vs 3 0.557
[F+K+A375SM+W] vs [F+K+C8161+W] 2.5 vs 3 0.557
F = Fibroblasts, K = Keratinocytes, W = Wound, Fn = Fibrin clots, TNF = 300U/ml TNF-α, Unloaded
Gel = Hydrogel without Sodium Ibuprofen. NaIbu100μM Gel = Sodium Ibuprofen hydrogel 100μM.
* p˂0.05
** p˂0.01.
doi:10.1371/journal.pone.0156931.t004
Table 5. Effects of Melanoma Cells onWound Healing in TE Skin.
Skin Constructs
HBL Cells A375SM Cells C8161 Cells
No Healing 15 3 0
Intermediate Healing 3 6 0
Good Healing 2 9 7
doi:10.1371/journal.pone.0156931.t005
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We suggest the interplay beween melanoma cells and normal skin cells creates a tumour
microenvironment around tumour cells.
Tumour microenvironments have been a long-term subject of study [25]. Melanoma cells
may interact with other cells such as fibroblasts, endothelial cells and immune cells through
paracrine and endocrine mechanisms as well as through direct contact via cell-to-cell and cell-
to-matrix adhesion and gap junctional intercellular communication. In normal skin, keratino-
cytes tightly control melanocyte behaviour and prevent their movement into the dermis but
once melanocytes become melanoma cells they acquire the ability to migrate and invade into
the dermis.
In contrast to the results of this study fibroblasts have been reported to promote tumour cell
invasion and are described as Carcinoma-Associated Fibroblasts (CAFs) which contribute to
tumour invasion and metastasis [26]. Indeed strategic therapeutic targeting of CAFs to treat
skin cancer and melanoma has been proposed [27, 28]. Fibroblasts have also been reported to
decrease the cytotoxic effects of drugs on melanoma cells [29], assisting the development of
chemoresistance to doxorubicin [30] in melanoma cells.
Thus the ability of fibroblasts to reduce melanoma cell invasion in our TE skin opposes
most results in the literature. However there are other studies which suggest fibroblasts may
oppose progression of skin cancers. One study demonstrated a decreased proportion of senes-
cent fibroblasts in geriatric skin that may play a role in preventing the initiation of skin cancer
[31]. It has been suggested that senescent fibroblasts may create a prooncogenic skin microen-
vironment that cooperates with mutant melanocytes to drive melanoma initiation and progres-
sion and should, therefore, be considered as a potential future therapeutic target [32]. This
suggests that fibroblasts may normally retard invasion but when they become senescent they
may assist invasion. [33].
Does the active or inactive state of the fibroblast influence metastasis? In our experiments
the TE skin model is only cultured for around two weeks—in some of these studies we wound
the TE skin. It is likely that the fibroblasts are metabolically active in these models. This sug-
gests an area for investigation—to deliberately introduce melanoma cells into TE skin environ-
ments with fibroblasts cultured to be either metabolically active or to be senescent to explore
this further.
Very recently we have confirmed that the area surrounding the melanoma tumour cells in
these models is abnormal using Raman spectroscopy [33]. The most striking feature of this
study was the finding of a high level of glycogen indicative of metabolically active cells sur-
rounding the melanoma tumour cells.
Prior work from our group has shown that for some melanoma cells to invade in a 3D
reconstructed skin model the presence of fibroblasts and keratinocytes are required [34]. How-
ever, it does not follow that the melanoma cells themselves upregulate degradative enzymes as
we initially thought. A subsequent study from our group showed that MMP-2 and MMP-9
were not upregulated in invading melanoma cells but in the surrounding keratinocytes and
fibroblasts [13, 34]. We suggest that the skin cells in modifying and organising the dermal
matrix, with upregulation of matrix metalloproteinases, create a matrix conducive to mela-
noma cell invasion.
Keratinocytes normally play a major role in skin healing and ECM (Extracellular Matrix)
breakdown and remodelling, both in their own right and by interacting with fibroblasts. Some
of these activities–breakdown of the dermis–would seem to provide an easy environment for
melanoma migration. Other activities—fibroblast synthesis of new collagen and its crosslink-
ing–would seem to be anti-invasive. Thus, it appears that melanoma cells can both influence
and be influenced by the surrounding skin cells.
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Normal cells need contact with the ECM which regulates their anchorage and their cell
cycle and the partial loss of these requirements is a hallmark of malignant cells. There is an
extensive literature describing how integrin mediated contact between malignant cells and the
ECM influences their behaviour [35].
In this study, HBL cells were weakly invasive but invasion in the dermis was significantly
increased following mechanical wounding. For these wounded TE models invasion was
reduced by the addition of TNF-α or fibrin plus TNF-α. The addition of sodium ibuprofen
slightly reduced invasion but this did not achieve statistical significance almost certainly due to
the relatively low number of these experiments in this study.
A375SM cells are moderately invasive cells whose invasion was slightly increased following
wounding. The addition of ibuprofen hydrogel significantly reduced A375SM cell invasion in a
wounded skin construct supporting the anti-invasive effects of NSAIDs in reducing melanoma
cell invasion as demonstrated in an artificial wound bed.
Finally, C8161 cells showed extensive invasion pre-wounding and post wounding. This was
not changed by the addition of fibrin plus TNF-α or the addition of ibuprofen. Essentially
these cells remained aggressively invasive under all conditions.
Concerning TE skin healing after wounding, the wounded model containing fibroblasts or
fibroblasts plus fibrin showed good healing. This may be explained by the provision of a tem-
porary fibrin clot scaffold for cell migration and the fibroblasts to synthesise new dermal extra-
cellular matrix components, as demonstrated by Rizzi et al. (2010) [36]. Standard TE skin
constructs to which fibrin and TNF-α were added healed relatively well. In terms of invasion
and healing properties, HBL cells were less invasive than the other melanoma cell lines but
they clearly also delayed wound healing in the TE skin constructs. A375SM cells showed an
intermediate level of invasiveness and wound healing. On the other hand, C8161 cells were the
most invasive of all three cell lines and unexpectedly resulted in good wound healing in all
constructs.
The slow healing process in wounded TE skin constructs with two of the melanoma cells
(HBL and A375SM) may be relevant to the ulceration seen with some melanomas. This can be
observed in a study of Balch et al., 2009 [37] who reported that patients with regional metasta-
sis also had ulceration of the primary melanoma. Possibly, some melanoma cells may retard
wound healing—with associated sustained inflammation. Conversely, the most aggressive mel-
anoma cell line, C8161, invaded without influencing wound healing. This may be related to the
expression of CD44 and hyaluronan on these C8161 cells, as reported by Edward et al. (2005)
[38] but clearly the results we report in this in vitro model for the first time will need further
investigation beyond this study.
It has been reported that following initial surgery designed to fully excise tumours, 20–50%
of patients develop local recurrences [39] and survival for these patients is reduced compared
to patients who do not develop local recurrences [39, 40]. Clinical experience records the phe-
nomena of “local recurrence” of melanomas which can occur some months after excision from
primary tumour sites. One theory which has only been investigated to a slight extent is that the
act of excision of primary melanoma creates a wound bed environment with upregulation of
degradative enzymes and pro-inflammatory cytokines which is conducive to the subsequent
attachment and migration of circulating melanoma cells. This has been investigated and con-
firmed in an animal model [14].
There are now many studies suggesting inflammation can exacerbate tumour metastases in
humans and in animals [41–42]. Our previous studies in this area have shown that TNF-α
increases melanoma cell invasion and migration in vitro [16, 18] and that anti-inflammatory
agents such as α-MSH (alpha-Melanocyte Stimulating Hormone) can reduce melanoma cell
invasion and protect cells against pro-inflammatory cytokine attack in cells with the wild-type
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receptor (HBL) [16]. Also, we have shown aspirin [17] can effectively inhibit TNF-α -induced
upregulation of NF-kappaB and ICAM-1 expression during in vitro migration and invasion of
human melanoma cells. More recently we demonstrated similar results for Ibuprofen [19].
Our results show that in this model ibuprofen significantly reduced melanoma invasion in
one out of three melanoma cell lines and showed a tendency to reduce invasion in another. It
was without effect in the third, very aggressively metastatic melanoma cell line. Clearly now
that this model is established it will need extending to other melanoma cell lines to establish
how widespread the actions of an anti-inflammatory might be in retarding melanoma invasion.
We suggest this study significantly extends our previous studies showing melanoma cells inter-
act with skin cells in their invasion into TE skin but also shows for the first time that fibroblasts
on their own tend to inhibit the invasion of melanoma cells and that ibuprofen can reduce mel-
anoma invasion under conditions designed to model some of the key features of removal of a
primary melanoma–the creation of a wound and the presence of associated inflammation. The
use of a tissue engineering approach allows one to study these as separate features—something
not easily possible in in vivo studies. These results held true for the two least invasive mela-
noma cell lines but unfortunately ibuprofen was without effect on the invasion of the very
aggressive C8161 cells in this model.
This study suggests that non-steroidal anti-inflammatory drugs used topically may be a use-
ful therapeutic approach to oppose the stimulatory effects of inflammation on melanoma
invasion.
With respect to the use of anti-inflammatories clinically there are a few reports using sys-
temic COX (Cyclooxygenase) inhibitors, such as Pioglitazone and Rofecoxib in the manage-
ment of melanoma [43, 44]. Also Lejeune et al, (2006) [45] reported a case study of a patient
with a metastatic melanoma of the leg who experienced sustained regression of skin metastases
upon continuous single treatment with the cyclooxygenase-2 inhibitor Rofecoxib.
Implications of this Study
In this study we propose that the spread of melanoma can be prevented by early diagnosis of a
primary cutaneous melanoma and topical treatment post-surgery with a local application of a
NSAID such as ibuprofen. The justification for giving the latter is to reduce the inflammatory
wound bed conditions post-surgery which we suggest are conducive to melanoma metastasis.
We suggest the beneficial effects of NSAIDs on primary melanoma may indicate its use as a
co-adjuvant topical agent in chemotherapy for treating melanoma but clearly more work will
be needed to establish this using this or a similar model.
Clearly these results must be interpreted with caution as this is an in vitro study without a
functioning immune system or any vasculature. The evidence presented from this 3D recon-
structed skin suggests that mechanical wounding is associated with increased invasion of mela-
noma cells (as demonstrated by the A375SM melanoma model) but that this can be attenuated
by the addition of ibuprofen (either as free drug or released from a hydrogel). If one relates
these findings to the phenomena of local recurrence of melanoma then there is an argument to
be made for reducing inflammation at the site of melanoma excision following excision of a
primary melanoma. This could be achieved by the addition of ibuprofen either systemically or
possibly, more effectively by its release from a hydrogel preparation placed on the wound bed
post-surgery. Interestingly the results also indicated that there was less damage to the dermis
following wounding when ibuprofen was administered in this model. Topical treatment with
ibuprofen is often used as a therapeutic approach to the reduction of wound pain in patients
with chronic, exuding leg ulcers [46, 47]. We suggest this study provides further evidence to
support the use of topical ibuprofen at the time of melanoma surgery.
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Conclusion
In conclusion studies using a 3D tissue engineered human skin model containing melanoma
cells suggest wounding increases melanoma cell invasion in an inflamed microenvironment.
These in vitro results support the hypothesis that the local addition of an anti-inflammatory
drug such as ibuprofen can attenuate melanoma invasion and may promote healing post surgi-
cal excision of primary tumours but further work will be required with other cell lines to estab-
lish how widespread or otherwise this effect of ibuprofen may be.
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